Plumbagin caged silver nanoparticle stabilized collagen scaffold for wound dressing

Area of Science:

• Biomaterials Science
• Nanotechnology
• Regenerative Medicine

Background:

• Developing advanced wound dressings is crucial for effective healing.
• Collagen scaffolds offer a promising base but require modification for enhanced therapeutic properties.
• Nanoparticle integration presents a strategy to improve scaffold performance.

Purpose of the Study:

• To develop a novel collagen scaffold using plumbagin-caged silver nanoparticles (PCSN) as a cross-linking agent.
• To evaluate the antimicrobial and wound healing capabilities of the PCSN-modified collagen scaffold.
• To investigate the impact of PCSN cross-linking on the physical, thermal, mechanical, and structural properties of collagen.

Main Methods:

• Synthesized plumbagin-caged silver nanoparticles (PCSN).
• Utilized PCSN as a cross-linking agent for collagen scaffolds.
• Characterized scaffold properties using FTIR and CD analysis.
• Assessed antimicrobial activity and in vitro cell proliferation.

Main Results:

• PCSN cross-linking significantly enhanced the physical, thermal, and mechanical properties of collagen scaffolds.
• Scaffolds exhibited uniform collagen fibril alignment and ordered porous structures.
• PCSN-modified scaffolds demonstrated potent anti-bacterial activity and promoted cell proliferation.
• The synergistic effect of plumbagin and silver nanoparticles in PCSN was responsible for the observed therapeutic benefits.

Conclusions:

• Plumbagin-caged silver nanoparticles effectively cross-link collagen scaffolds, improving their structural and functional attributes.
• The developed PCSN-collagen scaffold possesses significant antimicrobial and wound healing potential.
• This nano-biotechnological approach offers a promising strategy for advanced wound dressing development.